Healthtech Startups

Dezhen Technology provides information technology solutions and IT strategy consulting for hospitals and medical institutions, covering clinical care, research, and management. Services include hospital IT strategy design, implementation planning, information system deployment, and staff training for information management departments.

1 investor

Dharmalife is a social impact organisation founded in 2009 that trains rural women in India as entrepreneurs (Dharma Life Entrepreneurs) to distribute socially impactful products and services to rural households. It operates through a not-for-profit, a foundation, and a for-profit last-mile distribution arm, focusing on livelihoods, behaviour change, and women's economic independence in rural India.

1 investor

DHNY organizes events and content sharing platforms that connect professionals in the digital health industry to exchange innovations and ideas.

1 investor

DiabeTech develops an AI-powered biosensor sock and mobile platform to detect diabetic foot complications and ulcers at an early stage, serving patients and healthcare providers. The company operates in the digital health and medical device space, partnering with healthcare systems and clinics across the United States.

1 investor

A nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.

1 investor

ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.

1 investor

Diadem Bio develops therapeutic treatments designed to be safe, powerful, versatile and cost-effective for patients with unmet medical needs, with a focus on potential cancer cures and other difficult diseases.

1 investor

Hologic Diagenode provides epigenomics profiling services and sample preparation products for next-generation sequencing, proteomics, and epigenetics research. It serves biomarker discovery and validation through epigenomics and bioinformatics for research applications.

1 investor

Diagna builds AI technology to automate administrative work in healthcare clinics, helping medical staff focus on patient care by handling information management tasks like form processing, faxes, and data coordination.

1 investor

1 investor

Diagnostikare is a physician-designed digital health platform that combines technology with human support to deliver reliable, people-centered healthcare experiences. It offers companies an integrated solution to support employee health and improve health-related decision-making.

1 investor

DIAGNOSTYKA operates a network of medical sample collection points and offers laboratory tests and test packages, including online purchase, results retrieval, and online consultations. It serves patients in Poland seeking diagnostic laboratory testing.

1 investor

Backline is a healthcare communication and coordination platform that helps hospital teams manage clinical workflows like care coordination, consults, patient engagement, and case management. Part of DrFirst, it provides task accountability and escalation features built on secure messaging infrastructure trusted by 1,500+ healthcare facilities.

1 investor

Diakoniestation Stuttgart is an outpatient nursing service (ambulanter Pflegedienst) providing home-based care to help people live independently at home. It operates in Stuttgart, Germany.

1 investor

Diamante develops plant-based compounds for therapeutic and diagnostic systems targeting autoimmune diseases. The company applies molecular farming techniques to produce biopharmaceuticals and aims to advance treatments from research to clinical applications.

1 investor

Diamidex develops microbiological analysis solutions for water safety, including equipment, software, and reagents designed to detect and count targeted microorganisms with improved speed and accuracy for laboratory use.

1 investor

Dianthus Therapeutics develops antibody-based therapies for patients with severe autoimmune diseases, including its lead complement C1s inhibitor claseprubart (DNTH103) and a bifunctional inhibitor DNTH212 designed for self-administered subcutaneous injection. The company operates in the biotech and drug development sector.

1 investor

Diasome develops metabolic therapies using its HDV platform to enable targeted drug delivery for treating diabetes, obesity, and metabolic diseases. The company focuses on translating therapeutic insights to restore metabolic function using endogenous mechanisms.

1 investor

Diatech Diabetes is a medical device company developing SmartFusion, a software platform and mobile app that monitors insulin infusion pumps for medication delivery failure and measures the accuracy of insulin delivery for people living with diabetes. The technology is in development and its core assets and IP have been acquired by DEKA Research & Development.

1 investor

DIATER develops diagnostic tools and therapeutic treatments for allergy patients using molecular immunotherapy techniques. The company manufactures personalized therapies for complex allergies and operates across Spain, Portugal, and Germany.

1 investor

DICOM Director develops medical imaging software that converts 2D CT and MRI scans into anatomically accurate 3D holograms viewable on augmented and virtual reality devices for clinicians. Its tools support diagnosis, therapy guidance, and secure study sharing between healthcare providers.

1 investor

Diesse develops and manufactures in-vitro diagnostic instruments and reagents for clinical laboratories, including automated ESR (erythrocyte sedimentation rate) analyzers, automated and manual immunoassay systems, and rapid diagnostic tests. Its product lines include VES-MATIC, CHORUS, AUTO-DAT, Enzywell, and iRapid.

1 investor

The Difference Card provides health insurance benefits solutions and cost-savings programs for small and mid-sized employers, helping them reduce healthcare expenses while maintaining comprehensive benefits coverage. The company offers multiple branded solutions including dental, wellness, health savings accounts, and budgeting tools designed to lower premiums and claims exposure.

1 investor

Digestiva develops proprietary protease enzymes that break down proteins to produce more bioaccessible and smaller peptides, increase free amino acid availability, and improve protein yield from co-products and waste streams. Its technology targets applications in health, nutrition, and food processing.

1 investor